Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death | |
Na R., Zheng S.L., Han M., Yu H., Jiang D., Shah S., Ewing C., Zhang L., Novakovic K., Petkewicz J., Gulukota K., Helseth D., Quinn M., Humphries E., Wiley K., Isaacs S., Wu Y., Liu X., Zhang N., Wang | |
刊名 | European Urology, Supplements |
2017 | |
卷号 | 16期号:3 |
ISSN号 | 1569-9056 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3617163 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Na R., Zheng S.L., Han M., Yu H., Jiang D., Shah S., Ewing C., Zhang L., Novakovic K., Petkewicz J., Gulukota K., Helseth D., Quinn M., Humphries E., Wiley K., Isaacs S., Wu Y., Liu X., Zhang N., Wang. Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death[J]. European Urology, Supplements,2017,16(3). |
APA | Na R., Zheng S.L., Han M., Yu H., Jiang D., Shah S., Ewing C., Zhang L., Novakovic K., Petkewicz J., Gulukota K., Helseth D., Quinn M., Humphries E., Wiley K., Isaacs S., Wu Y., Liu X., Zhang N., Wang.(2017).Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death.European Urology, Supplements,16(3). |
MLA | Na R., Zheng S.L., Han M., Yu H., Jiang D., Shah S., Ewing C., Zhang L., Novakovic K., Petkewicz J., Gulukota K., Helseth D., Quinn M., Humphries E., Wiley K., Isaacs S., Wu Y., Liu X., Zhang N., Wang."Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death".European Urology, Supplements 16.3(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论